
FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes
For Immediate Release: May 13, 2022 Today, the U.S. Food and Drug Administration approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise. Mounjaro was effective at …